Physician

Chandramouli Madala, MD

According to 2025 Medicare claims, Chandramouli Madala, MD (NPI: 1487629283) practices cardiology in the Battle Creek, MI market, with the plurality of this provider's patient population coming from Calhoun, MI. This provider's primary affiliated billing organization is ASCENSION MEDICAL GROUP PROMED (NPI: 1720009954; TIN: 383193801) and primary practice location at 49015-4334.

Madala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 466 traditional Medicare patients, billed 1,352 HCPCS/CPT codes, and received $72,417 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,446 prescription claims across 374 beneficiaries totaling $462,991 in drug costs, led by Eliquis (Apixaban). DME data shows 309 claims. Open Payments data shows 1 records totaling $20. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $247,936 to $72,417. In contrast, Part D prescription costs have risen steadily, from $14,404 to $462,991. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$125K$249K2015 Medicare payment: $247,936 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $249,460 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $216,620 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $187,906 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $155,769 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $35,991 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $63,010 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $62,238 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $70,209 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $72,417 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3804,044$247,936
20161,4084,284$249,460
20171,2693,730$216,620
20181,1403,455$187,906
20191,4373,303$155,769
2020264737$35,991
20213501,086$63,010
20224291,259$62,238
20234451,428$70,209
20244661,352$72,417

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$231K$463K2015 Drug cost: $14,404 (USD; Tot_Drug_Cst)2016 Drug cost: $28,610 (USD; Tot_Drug_Cst)2017 Drug cost: $30,874 (USD; Tot_Drug_Cst)2018 Drug cost: $70,842 (USD; Tot_Drug_Cst)2019 Drug cost: $83,441 (USD; Tot_Drug_Cst)2020 Drug cost: $64,553 (USD; Tot_Drug_Cst)2021 Drug cost: $118,418 (USD; Tot_Drug_Cst)2022 Drug cost: $262,595 (USD; Tot_Drug_Cst)2023 Drug cost: $414,261 (USD; Tot_Drug_Cst)2024 Drug cost: $462,991 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201582243$14,404
2016108489$28,610
2017124578$30,874
2018141770$70,842
2019118627$83,441
2020108487$64,553
20212051,082$118,418
20222621,550$262,595
20233011,936$414,261
20243742,446$462,991

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$767K$1.5M2024 Medicare payment: $1,534,581 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024309309$1,534,581

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more7676$85
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more424890$64
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function142143$45
93227Electrocardiogram (ecg) 2-day continuous with review by health care professional2727$12
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only157165$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban23812,767$237,773
XareltoRivaroxaban1487,653$137,339
EntrestoSacubitril/Valsartan201,260$27,652
Metoprolol SuccinateMetoprolol Succinate48328,383$5,481
Atorvastatin CalciumAtorvastatin Calcium24715,359$2,839

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4353Intermittent urinary catheter, with insertion suppliesN117117$827,452
A6197Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressingN7676$624,679
L1852Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelfN4040$39,719
L0651Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelfN3737$24,434
L3916Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelfN3939$18,297

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$20Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Chandramouli Madala, MD?

Tedicare shows public-source Medicare data for Chandramouli Madala, MD (NPI 1487629283), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chandramouli Madala, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chandramouli Madala, MD?

Chandramouli Madala, MD is linked to ASCENSION MEDICAL GROUP PROMED (billing NPI 1720009954) in the available physician profile data.

Does Chandramouli Madala, MD have Open Payments data?

Chandramouli Madala, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.